VR Adviser’s RayzeBio, Inc. Common Stock RYZB Stock Holding History

VR Adviser’s Portfolio RYZB Stock Details RYZB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-4,030,471	Closed	-$251M	–	44
2023 Q4	$251M	Buy	4,030,471 +13,624	+0.3%	+$339K	17.19%	1
2023 Q3	$89.2M	Buy	+4,016,847	New	+$84.3M	9.39%	2

VR Adviser's RYZB Position: Q1 2024 in Review

VR Adviser sold out of RayzeBio, Inc. Common Stock (RYZB) in Q1 2024, closing a stake of 4,030,471 shares — an estimated $251M sold.

VR Adviser first reported a position in RYZB in Q3 2023 and held it in 2 quarters. The position peaked at $251M in Q4 2023. 0 funds tracked by Wall St. Rank hold RYZB as of Q1 2024.

VR Adviser reported no remaining RayzeBio, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
VR Adviser sold 4,030,471 RayzeBio, Inc. Common Stock shares in Q1 2024, an estimated $251M.
VR Adviser first reported a position in RayzeBio, Inc. Common Stock in Q3 2023 and held it in 2 quarters.
VR Adviser's RayzeBio, Inc. Common Stock position peaked at $251M in Q4 2023.
0 funds tracked by Wall St. Rank held RayzeBio, Inc. Common Stock as of Q1 2024.

Based on VR Adviser's 13F filing for Q1 2024, filed 15 May 2024.